Long path to MYC inhibition approaches clinical trials
Sign Up to like & getrecommendations! Published in 2019 at "Nature Reviews Cancer"
DOI: 10.1038/s41568-019-0141-9
Abstract: Omomyc, a MYC dominant-negative gene product that is used to inhibit MYC for research purposes, can penetrate cancer cells in vitro and in vivo, bringing it closer to evaluation in the clinic. read more here.
Keywords: long path; inhibition approaches; path myc; myc inhibition ... See more keywords